Ewa Mędraś

488 total citations
7 papers, 60 citations indexed

About

Ewa Mędraś is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Ewa Mędraś has authored 7 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Hematology and 3 papers in Rheumatology. Recurrent topics in Ewa Mędraś's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Eosinophilic Disorders and Syndromes (3 papers). Ewa Mędraś is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Eosinophilic Disorders and Syndromes (3 papers). Ewa Mędraś collaborates with scholars based in Poland, Pakistan and United States. Ewa Mędraś's co-authors include Joanna Góra‐Tybor, Małgorzata Całbecka, Krzysztof Jamroziak, Tadeusz Robak, Tomasz Sacha, Bożena Jaźwiec, Tomasz Wróbel, Katarzyna Kapelko‐Słowik, Kazimierz Kuliczkowski and Sławomira Kyrcz‐Krzemień and has published in prestigious journals such as Blood, Cells and Disease Markers.

In The Last Decade

Ewa Mędraś

7 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Mędraś Poland 4 56 34 31 13 10 7 60
Nathalie Cheikh France 4 63 1.1× 14 0.4× 44 1.4× 5 0.4× 2 0.2× 8 82
A. Guerci-Bresler United States 4 161 2.9× 24 0.7× 145 4.7× 3 0.2× 12 1.2× 8 171
T. Cardillo United States 5 17 0.3× 30 0.9× 10 0.3× 7 0.5× 14 1.4× 7 55
Tatiana Zinger Lebanon 6 74 1.3× 3 0.1× 88 2.8× 10 0.8× 6 0.6× 7 112
Amber M. Yates United States 6 47 0.8× 7 0.2× 53 1.7× 1 0.1× 8 0.8× 10 78
Stefanie Slot Netherlands 5 28 0.5× 9 0.3× 26 0.8× 8 0.8× 10 61
Vera Yablokova Austria 5 24 0.4× 27 0.8× 36 1.2× 4 0.4× 8 43
Majda Benedik‐Dolničar Slovenia 6 42 0.8× 14 0.4× 10 0.3× 4 0.3× 12 59
Sanjay Pathare United Kingdom 4 20 0.4× 39 1.1× 3 0.1× 3 0.2× 4 0.4× 7 60
Agostina Siniscalchi Italy 7 87 1.6× 11 0.3× 23 0.7× 2 0.2× 44 4.4× 16 107

Countries citing papers authored by Ewa Mędraś

Since Specialization
Citations

This map shows the geographic impact of Ewa Mędraś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Mędraś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Mędraś more than expected).

Fields of papers citing papers by Ewa Mędraś

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Mędraś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Mędraś. The network helps show where Ewa Mędraś may publish in the future.

Co-authorship network of co-authors of Ewa Mędraś

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Mędraś. A scholar is included among the top collaborators of Ewa Mędraś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Mędraś. Ewa Mędraś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zaleska, Joanna, Ewa Wasilewska, Iwona Hus, et al.. (2024). High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation. Cells. 13(8). 723–723. 1 indexed citations
2.
3.
Sacha, Tomasz, Joanna Góra‐Tybor, Olga Grzybowska‐Izydorczyk, et al.. (2016). Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry. Blood. 128(22). 629–629. 2 indexed citations
4.
Góra‐Tybor, Joanna, Tomasz Sacha, Olga Grzybowska‐Izydorczyk, et al.. (2016). Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 470 Patients from the Polish Adult Leukemia Group (PALG) Registry. Blood. 128(22). 1909–1909. 1 indexed citations
5.
Dybko, Jarosław, Bożena Jaźwiec, Olga Haus, et al.. (2016). The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience. Disease Markers. 2016. 1–5. 6 indexed citations
6.
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Cheikh Breakdown of academic impact, for papers by A. Guerci-Bresler Breakdown of academic impact, for papers by T. Cardillo Breakdown of academic impact, for papers by Tatiana Zinger Breakdown of academic impact, for papers by Amber M. Yates Breakdown of academic impact, for papers by Stefanie Slot Breakdown of academic impact, for papers by Vera Yablokova Breakdown of academic impact, for papers by Majda Benedik‐Dolničar Breakdown of academic impact, for papers by Sanjay Pathare Breakdown of academic impact, for papers by Agostina Siniscalchi
Rankless by CCL
2026